Murthy S C, Eaves C J, Krystal G
Terry Fox Laboratory, British Columbia Cancer Research Centre, Vancouver.
Exp Hematol. 1989 Nov;17(10):997-1003.
We have found that treatment of B6SUtA1 cells with 0.01% glutaraldehyde transformed them into mechanically resistant spheres, thereby making it possible to use these high interleukin 3 (IL-3) receptor-bearing cells as a solid phase reagent suitable for the large scale purification of murine IL-3 (mIL-3). Using this technique, mIL-3 was purified from serum-free pokeweed mitogen-stimulated spleen cell-conditioned medium (PWM-SCCM) approximately 16,000-fold using absorption to B6SUtA1 cells, Sephadex G75 superfine chromatography, and reverse phase high performance liquid chromatography on a C18 column. The overall yield was 16%. The final product consisted of two proteins with molecular weights of 19.5 and 16.5 kd. Both species possessed mIL-3-like activity. N-glycanase treatment of the purified preparation converted all of the 19.5-kd material into the lower molecular weight species, suggesting that the two species represented different glycosylated states of mIL-3 produced by activated T cells. This was confirmed by competition studies that showed that excess pure Escherichia coli-derived recombinant mIL-3, but not granulocyte-macrophage colony-stimulating factor (GM-CSF), could prevent the binding of both species of the PWM-SCCM-derived material to B6SUtA1 cells.
我们发现,用0.01%的戊二醛处理B6SUtA1细胞可将其转化为机械抗性球体,从而能够将这些携带高白细胞介素3(IL-3)受体的细胞用作适合大规模纯化小鼠IL-3(mIL-3)的固相试剂。利用该技术,通过吸附到B6SUtA1细胞、Sephadex G75超细柱色谱以及在C18柱上进行反相高效液相色谱,从无血清商陆有丝分裂原刺激的脾细胞条件培养基(PWM-SCCM)中纯化mIL-3,纯化倍数约为16000倍。总产率为16%。最终产物由两种分子量分别为19.5和16.5kd的蛋白质组成。这两种蛋白均具有mIL-3样活性。对纯化制剂进行N-糖苷酶处理后,所有19.5kd的物质都转化为较低分子量的物质,这表明这两种物质代表了活化T细胞产生的mIL-3的不同糖基化状态。竞争研究证实了这一点,该研究表明,过量的纯大肠杆菌衍生重组mIL-3(而非粒细胞-巨噬细胞集落刺激因子(GM-CSF))可阻止PWM-SCCM衍生物质的两种形式与B6SUtA1细胞结合。